Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2018-02-02 2018-01-10
Drug Identification Number 02091887 02091887
Brand name RIFADIN RIFADIN
Common or Proper name Rifadin 150mg Rifadin 150mg
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients RIFAMPIN RIFAMPIN
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100's 100's
ATC code J04AB J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-01-05 2018-01-05
Estimated end date 2018-01-30 2018-01-30
Actual end date 2018-01-31
Shortage status Resolved Actual shortage
Company comments Delay in supply Delay in supply
Health Canada comments